RT Journal
A1 Thompson WG, Gau GT
T1 HYpertriglyceridemia and its pharmacologic treatment among us adults—invited commentary
JF Archives of Internal Medicine
JO Archives of Internal Medicine
YR 2009
FD March 23
VO 169
IS 6
SP 578
OP 579
DO 10.1001/archinternmed.2008.594
UL http://dx.doi.org/10.1001/archinternmed.2008.594
AB 
Should hypertriglyceridemia be treated, and if so, how? Several authors have advocated pharmacologic therapy and have cited the NCEP report.2 However, the NCEP report advocates pharmacologic treatment only for TG concentrations higher than 500 mg/dL. The report advocates lifestyle change for TG concentrations between 150 and 500 mg/dL and says that pharmacologic therapy can be considered in high-risk persons in this group.